Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Giulia Coco, Giacomo Ambrosini, Silvia Poletti, Laura Antonia Meliante, Andrea Taloni, Vincenzo Scorcia & Giuseppe Giannaccare. (2023) Recent advances in drug treatments for dry eye disease. Expert Opinion on Pharmacotherapy 0:0, pages 1-21.
Read now
Read now
Giulia Coco, Andrea Taloni, Vincenzo Scorcia & Giuseppe Giannaccare. (2023) The vicious cycle of dry eye disease: a look into promising novel drug therapies. Expert Review of Ophthalmology 0:0, pages 1-13.
Read now
Read now
Javier Moreno-Montañés, Anne-Marie Bleau & Ana Isabel Jimenez. (2018) Tivanisiran, a novel siRNA for the treatment of dry eye disease. Expert Opinion on Investigational Drugs 27:4, pages 421-426.
Read now
Read now
Margarita Calonge, Marc Labetoulle, Elisabeth M. Messmer, Sunil Shah, Yonca A. Akova, Kostas G. Boboridis, Jesús Merayo-Lloves, Pasquale Aragona, José Benítez-Del-Castillo, Gerd Geerling, Maurizio Rolando & Christophe Baudouin. (2018) Controlled Adverse Environment Chambers in Dry Eye Research. Current Eye Research 43:4, pages 445-450.
Read now
Read now
John D. Rodriguez, Keith J. Lane, George W. Ousler$suffix/text()$suffix/text(), Endri Angjeli, Lisa M. Smith & Mark B. Abelson. (2018) Blink: Characteristics, Controls, and Relation to Dry Eyes. Current Eye Research 43:1, pages 52-66.
Read now
Read now
Candela Rodríguez-Pomar, Jesus Pintor, Basilio Colligris & Gonzalo Carracedo. (2017) Therapeutic inhibitors for the treatment of dry eye syndrome. Expert Opinion on Pharmacotherapy 18:17, pages 1855-1865.
Read now
Read now
Nariman Nassiri, Yasaira Rodriguez Torres, Zachary Meyer, Michael A. Beyer, Gautham Vellaichamy, Amar S. Dhaliwal, Neil Chungfat & Frank S. Hwang. (2017) Current and emerging therapy of dry eye disease. Part A: pharmacological modalities. Expert Review of Ophthalmology 12:4, pages 269-297.
Read now
Read now
Marcella Nebbioso, Valeria Fameli, Magda Gharbiya, Marta Sacchetti, Anna Maria Zicari & Alessandro Lambiase. (2016) Investigational drugs in dry eye disease. Expert Opinion on Investigational Drugs 25:12, pages 1437-1446.
Read now
Read now
George Ousler$suffix/text()$suffix/text(), Douglas K Devries, Paul M Karpecki & Joseph B Ciolino. (2015) An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye. Clinical Ophthalmology 9, pages 235-243.
Read now
Read now
Basilio Colligris, Almudena Crooke, Fernando Huete-Toral & Jesus Pintor. (2014) An update on dry eye disease molecular treatment: advances in drug pipelines. Expert Opinion on Pharmacotherapy 15:10, pages 1371-1390.
Read now
Read now
Murat Dogru, Masatsugu Nakamura, Jun Shimazaki & Kazuo Tsubota. (2013) Changing trends in the treatment of dry-eye disease. Expert Opinion on Investigational Drugs 22:12, pages 1581-1601.
Read now
Read now
Articles from other publishers (39)
Sudhanshu Shanker & Michel F. Sanner. (2023) Predicting Protein–Peptide Interactions: Benchmarking Deep Learning Techniques and a Comparison with Focused Docking. Journal of Chemical Information and Modeling 63:10, pages 3158-3170.
Crossref
Crossref
Joseph Tauber, David Evans, Bruce Segal, Xiao-Yan Li, Wang Shen, Caroline Lu, Gary D. Novack, Joseph Tauber, Marc Abrams, Robert Smyth-Medina, Parag Majmudar, Edward Holland, Louis Alpern, Joseph Martel, Emma Clay, Michael Korenfeld, Bruce Segal, John Goosey, David Evans, Damien Goldberg & Sherif El-Harazi. (2023) A phase 2a, double-masked, randomized, vehicle-controlled trial of VVN001 in subjects with dry eye disease. The Ocular Surface 28, pages 18-24.
Crossref
Crossref
Jennifer B. Nadelmann, Vatinee Y. Bunya, Ilaria Macchi & Mina Massaro-Giordano. 2023. Dry Eye Disease. Dry Eye Disease
153
179
.
Noriaki Nagai & Hiroko Otake. (2022) Novel drug delivery systems for the management of dry eye. Advanced Drug Delivery Reviews 191, pages 114582.
Crossref
Crossref
Gunnar Nordvall, Pontus Forsell & Johan Sandin. (2022) Neurotrophin-targeted therapeutics: A gateway to cognition and more?. Drug Discovery Today 27:10, pages 103318.
Crossref
Crossref
Jennifer B. Nadelmann, Angela Gupta, Caroline W. Chung & Stephen E. Orlin. (2022) Stepwise Approach to the Diagnosis and Management of Dry Eye and Ocular Surface Disease. Advances in Ophthalmology and Optometry 7:1, pages 325-344.
Crossref
Crossref
Hebatallah B. Mohamed, Basma N. Abd El-Hamid, Dina Fathalla & Ehab A Fouad. (2022) Current trends in pharmaceutical treatment of dry eye disease: A review. European Journal of Pharmaceutical Sciences 175, pages 106206.
Crossref
Crossref
Kai Jin, Yanni Ge, Ziqiang Ye, Xiangji Pan, Yan Yan, Zhengwei Mao & Juan Ye. (2022) Anti-oxidative and mucin-compensating dual-functional nano eye drops for synergistic treatment of dry eye disease. Applied Materials Today 27, pages 101411.
Crossref
Crossref
. 2022. Phytoconstituents and Antifungals. Phytoconstituents and Antifungals
121
146
.
Christopher E. Starr, Reza Dana, Stephen C. Pflugfelder, Edward J. Holland, Steven Zhang, Desiree Owen & Kim Brazzell. (2021) Dry eye disease flares: A rapid evidence assessment. The Ocular Surface 22, pages 51-59.
Crossref
Crossref
David Clark, Joseph Tauber, John Sheppard & Todd C. Brady. (2021) Early Onset and Broad Activity of Reproxalap in a Randomized, Double-Masked, Vehicle-Controlled Phase 2b Trial in Dry Eye Disease. American Journal of Ophthalmology 226, pages 22-31.
Crossref
Crossref
David ClarkJohn SheppardTodd C. Brady. (2021) A Randomized Double-Masked Phase 2a Trial to Evaluate Activity and Safety of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in Dry Eye Disease. Journal of Ocular Pharmacology and Therapeutics 37:4, pages 193-199.
Crossref
Crossref
Guruprasad R. Pattar, Gary Jerkins, David G. Evans, Gail L. Torkildsen, George W. Ousler, David A. Hollander, Mark Holdbrook & Michelle Senchyna. (2020) Symptom improvement in dry eye subjects following intranasal tear neurostimulation: Results of two studies utilizing a controlled adverse environment. The Ocular Surface 18:2, pages 249-257.
Crossref
Crossref
Preeya K. Gupta, Penny Asbell & John Sheppard. (2020) Current and Future Pharmacological Therapies for the Management of Dry Eye. Eye & Contact Lens: Science & Clinical Practice 46:2, pages S64-S69.
Crossref
Crossref
K. Xhima, K. Markham-CoultesH. NedevS. Heinen, H. U. SaragoviK. HynynenI. Aubert. (2020) Focused ultrasound delivery of a selective TrkA agonist rescues cholinergic function in a mouse model of Alzheimer’s disease. Science Advances 6:4.
Crossref
Crossref
Christophe Baudouin, Maurizio Rolando, Jose M. Benitez Del Castillo, Elisabeth M. Messmer, Francisco C. Figueiredo, Murat Irkec, Gysbert Van Setten & Marc Labetoulle. (2019) Reconsidering the central role of mucins in dry eye and ocular surface diseases. Progress in Retinal and Eye Research 71, pages 68-87.
Crossref
Crossref
Edward J. Holland, Mahshad Darvish, Kelly K. Nichols, Lyndon Jones & Paul M. Karpecki. (2019) Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: A systematic literature review. The Ocular Surface 17:3, pages 412-423.
Crossref
Crossref
Carolyn Begley, Barbara Caffery, Robin Chalmers, Ping Situ, Trefford Simpson & J. Daniel Nelson. (2019) Review and analysis of grading scales for ocular surface staining. The Ocular Surface 17:2, pages 208-220.
Crossref
Crossref
Marc Labetoulle, Christophe Baudouin, Margarita Calonge, Jesús Merayo‐Lloves, Kostas G. Boboridis, Yonca A. Akova, Pasquale Aragona, Gerd Geerling, Elisabeth M. Messmer & José Benítez‐del‐Castillo. (2018) Role of corneal nerves in ocular surface homeostasis and disease. Acta Ophthalmologica 97:2, pages 137-145.
Crossref
Crossref
Jolene L. Lau & Michael K. Dunn. (2018) Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorganic & Medicinal Chemistry 26:10, pages 2700-2707.
Crossref
Crossref
E. M. Messmer. (2017) Neue aktuelle und zukünftige Therapieoptionen in der Behandlung des trockenen AugesNovel current and future therapy options for treatment of dry eye disease. Der Ophthalmologe 115:2, pages 100-106.
Crossref
Crossref
Anat Galor, Hamid-Reza Moein, Charity Lee, Adriana Rodriguez, Elizabeth R. Felix, Konstantinos D. Sarantopoulos & Roy C. Levitt. (2018) Neuropathic pain and dry eye. The Ocular Surface 16:1, pages 31-44.
Crossref
Crossref
George W. OuslerIIIIII, David Rimmer, Lisa M. Smith & Mark B. Abelson. (2017) Use of the Controlled Adverse Environment (CAE) in Clinical Research: A Review. Ophthalmology and Therapy 6:2, pages 263-276.
Crossref
Crossref
Peter CorcoranDavid A. HollanderGeorge W. OuslerIIIIIIEndri AngjeliDavid RimmerKeith LaneMark B. Abelson. (2017) Dynamic Sensitivity of Corneal TRPM8 Receptors to Menthol Instillation in Dry Eye Versus Normal Subjects. Journal of Ocular Pharmacology and Therapeutics 33:9, pages 686-692.
Crossref
Crossref
Yunes Panahi, Seyyed Mahdi Rajaee & Amirhossein Sahebkar. (2017) Ocular Effects of Sulfur Mustard and Therapeutic Approaches. Journal of Cellular Biochemistry 118:11, pages 3549-3560.
Crossref
Crossref
Marcella Nebbioso, Paola Del Regno, Magda Gharbiya, Marta Sacchetti, Rocco Plateroti & Alessandro Lambiase. (2017) Analysis of the Pathogenic Factors and Management of Dry Eye in Ocular Surface Disorders. International Journal of Molecular Sciences 18:8, pages 1764.
Crossref
Crossref
Gary D. Novack, Penny Asbell, Stefano Barabino, Michael V.W. Bergamini, Joseph B. Ciolino, Gary N. Foulks, Michael Goldstein, Michael A. Lemp, Stefan Schrader, Craig Woods & Fiona Stapleton. (2017) TFOS DEWS II Clinical Trial Design Report. The Ocular Surface 15:3, pages 629-649.
Crossref
Crossref
Lyndon Jones, Laura E. Downie, Donald Korb, Jose M. Benitez-del-Castillo, Reza Dana, Sophie X. Deng, Pham N. Dong, Gerd Geerling, Richard Yudi Hida, Yang Liu, Kyoung Yul Seo, Joseph Tauber, Tais H. Wakamatsu, Jianjiang Xu, James S. Wolffsohn & Jennifer P. Craig. (2017) TFOS DEWS II Management and Therapy Report. The Ocular Surface 15:3, pages 575-628.
Crossref
Crossref
Margarita Calonge, Jose Pinto-Fraga, María J. González-García, Amalia Enríquez-de-Salamanca, Alberto López-de la Rosa, Itziar Fernández & Alberto López-Miguel. (2017) Effects of the External Environment on Dry Eye Disease. International Ophthalmology Clinics 57:2, pages 23-40.
Crossref
Crossref
Mark S. Milner, Kenneth A. Beckman, Jodi I. Luchs, Quentin B. Allen, Richard M. Awdeh, John Berdahl, Thomas S. Boland, Carlos Buznego, Joseph P. Gira, Damien F. Goldberg, David Goldman, Raj K. Goyal, Mitchell A. Jackson, James Katz, Terry Kim, Parag A. Majmudar, Ranjan P. Malhotra, Marguerite B. McDonald, Rajesh K. Rajpal, Tal Raviv, Sheri Rowen, Neda Shamie, Jonathan D. Solomon, Karl Stonecipher, Shachar Tauber, William Trattler, Keith A. Walter, George O. Waring, Robert J. Weinstock, William F. Wiley & Elizabeth Yeu. (2017) Dysfunctional tear syndrome. Current Opinion in Ophthalmology 28:SUPPLEMENT 1, pages 3-47.
Crossref
Crossref
Sylvia Josephy-Hernandez, Sean Jmaeff, Iulia Pirvulescu, Tahar Aboulkassim & H. Uri Saragovi. (2017) Neurotrophin receptor agonists and antagonists as therapeutic agents: An evolving paradigm. Neurobiology of Disease 97, pages 139-155.
Crossref
Crossref
Alessandro Lambiase, Benjamin D. Sullivan, Tannin A. Schmidt, David A. Sullivan, Gregory D. Jay, Edward R. TruittIIIIII, Alice Bruscolini, Marta Sacchetti & Flavio Mantelli. (2017) A Two-Week, Randomized, Double-masked Study to Evaluate Safety and Efficacy of Lubricin (150 μg/mL) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops (Vismed®) in Patients with Moderate Dry Eye Disease. The Ocular Surface 15:1, pages 77-87.
Crossref
Crossref
Tanima Bose, Maria Diedrichs-Möhring & Gerhild Wildner. (2016) Dry eye disease and uveitis: A closer look at immune mechanisms in animal models of two ocular autoimmune diseases. Autoimmunity Reviews 15:12, pages 1181-1192.
Crossref
Crossref
John D. Rodriguez, Keith J. Lane, George W. Ousler, Endri Angjeli, Lisa M. Smith, Kirk M. Bateman & Mark B. Abelson. (2016) Diurnal Tracking of Blink and Relationship to Signs and Symptoms of Dry Eye. Cornea 35:8, pages 1104-1111.
Crossref
Crossref
Y. A. Sidorova & M. Saarma. (2016) Glial cell line-derived neurotrophic factor family ligands and their therapeutic potential. Molecular Biology 50:4, pages 521-531.
Crossref
Crossref
Wendy Chao, Carlos Belmonte, José M. Benitez del Castillo, Anthony J. Bron, Harminder S. Dua, Kelly K. Nichols, Gary D. Novack, Stefan Schrader, Mark D. Willcox, James S. Wolffsohn & David A. Sullivan. (2016) Report of the Inaugural Meeting of the TFOS i2 = initiating innovation Series: Targeting the Unmet Need for Dry Eye Treatment. The Ocular Surface 14:2, pages 264-316.
Crossref
Crossref
Ashiyana Nariani & Preeya K. Gupta. (2016) Dry Eye and Refractive Surgery Outcomes. Current Ophthalmology Reports 4:1, pages 8-14.
Crossref
Crossref
Laura A. Vickers & Preeya K. Gupta. (2015) The Future of Dry Eye Treatment: A Glance into the Therapeutic Pipeline. Ophthalmology and Therapy 4:2, pages 69-78.
Crossref
Crossref
Nisreen S. Ezuddin, Karam A. Alawa & Anat Galor. (2015) Therapeutic Strategies to Treat Dry Eye in an Aging Population. Drugs & Aging 32:7, pages 505-513.
Crossref
Crossref